The Histone Deacetylase Inhibitor Valproic Acid Exerts a Synergistic Cytotoxicity with the DNA-Damaging Drug Ellipticine in Neuroblastoma Cells

Neuroblastoma Cells ◽

Deacetylase Inhibitor ◽

Synergistic Cytotoxicity

Reprogramming of neuroblastoma cells by the histone deacetylase inhibitor valproic acid

Klinische Pädiatrie ◽

10.1055/s-2004-828557 ◽

2004 ◽

Vol 216 (03) ◽

Author(s):

H Deubzer ◽

J Schulte ◽

L Schweigerer ◽

J Hoheisel ◽

O Witt

Keyword(s):

Valproic Acid ◽

Histone Deacetylase ◽

Neuroblastoma Cells ◽

Effects of the histone deacetylase inhibitor valproic acid on Notch signalling in human neuroblastoma cells

British Journal of Cancer ◽

10.1038/sj.bjc.6602309 ◽

2005 ◽

Vol 92 (4) ◽

pp. 751-759 ◽

Cited By ~ 74

Author(s):

M-T Stockhausen ◽

J Sjölund ◽

C Manetopoulos ◽

H Axelson

Keyword(s):

Valproic Acid ◽

Histone Deacetylase ◽

Neuroblastoma Cells ◽

Notch Signalling ◽

Human Neuroblastoma Cells ◽

Human Neuroblastoma ◽

Effect of histone deacetylase inhibitor valproic acid on progenitor cells of acute myeloid leukemia

Haematologica ◽

10.3324/haematol.10758 ◽

2007 ◽

Vol 92 (4) ◽

pp. 542-545 ◽

Cited By ~ 35

Author(s):

G. Bug ◽

K. Schwarz ◽

C. Schoch ◽

M. Kampfmann ◽

R. Henschler ◽

...

Keyword(s):

Valproic Acid ◽

Acute Myeloid Leukemia ◽

Progenitor Cells ◽

Histone Deacetylase ◽

Myeloid Leukemia ◽

Deacetylase Inhibitor ◽

Acute Myeloid

Pretreatment with valproic acid, a histone deacetylase inhibitor, enhances the sensitivity of the peripheral blood micronucleus assay in rodents

Mutation Research/Genetic Toxicology and Environmental Mutagenesis ◽

10.1016/j.mrgentox.2012.10.009 ◽

2013 ◽

Vol 751 (1) ◽

pp. 19-26 ◽

Cited By ~ 8

Author(s):

T. Ahmad ◽

K. Shekh ◽

S. Khan ◽

A. Vikram ◽

L. Yadav ◽

...

Keyword(s):

Valproic Acid ◽

Histone Deacetylase ◽

Peripheral Blood ◽

Micronucleus Assay ◽

Radioprotective effects of valproic acid, a histone deacetylase inhibitor, in the rat brain

Biomedical Reports ◽

10.3892/br.2014.367 ◽

2014 ◽

Vol 3 (1) ◽

pp. 63-69 ◽

Cited By ~ 4

Author(s):

YONG ZHOU ◽

JUNJIE NIU ◽

SHUPENG LI ◽

HUAYING HOU ◽

YING XU ◽

...

Keyword(s):

Valproic Acid ◽

Rat Brain ◽

Histone Deacetylase ◽

THE CIRCADIAN EXPRESSION OF c-MYC IS MODULATED BY THE HISTONE DEACETYLASE INHIBITOR TRICHOSTATIN A IN SYNCHRONIZED MURINE NEUROBLASTOMA CELLS

Chronobiology International ◽

10.3109/07420521003786800 ◽

2010 ◽

Vol 27 (4) ◽

pp. 722-741 ◽

Cited By ~ 14

Author(s):

Anastasia Repouskou ◽

Thomae G. Sourlingas ◽

Kalliope E. Sekeri-Pataryas ◽

Anastasia Prombona

Keyword(s):

Histone Deacetylase ◽

Histone Deacetylase Inhibitor Trichostatin

Trichostatin A ◽

Neuroblastoma Cells ◽

Murine Neuroblastoma ◽

Circadian Expression ◽

Deacetylase Inhibitor ◽

A phase I–II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanoma

British Journal of Cancer ◽

10.1038/sj.bjc.6604817 ◽

2009 ◽

Vol 100 (1) ◽

pp. 28-36 ◽

Cited By ~ 48

Author(s):

A Rocca ◽

S Minucci ◽

G Tosti ◽

D Croci ◽

F Contegno ◽

...

Keyword(s):

Valproic Acid ◽

Phase I ◽

Histone Deacetylase ◽

Advanced Melanoma ◽

Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma

Journal of Molecular Medicine ◽

10.1007/s00109-018-1697-7 ◽

2018 ◽

Vol 96 (12) ◽

pp. 1307-1318 ◽

Cited By ~ 3

Author(s):

Wei-Chou Lin ◽

Fu-Shun Hsu ◽

Kuan-Lin Kuo ◽

Shing-Hwa Liu ◽

Chia-Tung Shun ◽

...

Keyword(s):

Urothelial Carcinoma ◽

Histone Deacetylase ◽

Trichostatin A ◽

Erk Pathway ◽

Deacetylase Inhibitor ◽

Synergistic Cytotoxicity

Association of Valproic Acid Use, a Potent Histone Deacetylase Inhibitor, and Melanoma Risk

Journal of Investigative Dermatology ◽

10.1016/j.jid.2020.04.007 ◽

2020 ◽

Vol 140 (12) ◽

pp. 2353-2358

Author(s):

Afton Chavez ◽

Charles P. Quesenberry ◽

Jeanne Darbinian ◽

Maryam M. Asgari

Keyword(s):

Valproic Acid ◽

Histone Deacetylase ◽

Melanoma Risk ◽

Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma

Journal of Molecular Medicine ◽

10.1007/s00109-019-01748-2 ◽

2019 ◽

Vol 97 (3) ◽

pp. 435-436

Author(s):

Wei-Chou Lin ◽

Fu-Shun Hsu ◽

Kuan-Lin Kuo ◽

Shing-Hwa Liu ◽

Chia-Tung Shun ◽

...

Keyword(s):

Urothelial Carcinoma ◽

Histone Deacetylase ◽

Trichostatin A ◽

Erk Pathway ◽

Deacetylase Inhibitor ◽

Synergistic Cytotoxicity